Combotope Therapeutics
PrivateLast Round
Accelerator
Mar 10, 2026
Total Funding Raised
$580,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Combotope Therapeutics operates in Healthcare & Life Sciences and is based in Copenhagen. Its latest recorded funding round was an Accelerator round in March 2026.
Combotope Therapeutics is a Danish biotechnology company that pioneers the discovery of highly tumor-selective antibodies by targeting cancer-specific glycan-protein epitopes.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Combotope Therapeutics Comparables
Compare Combotope Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GO Therapeutics | 88% | |
| TegMine Therapeutics | 85% | |
| Palleon Pharmaceuticals | 77% |
For institutional investors. Book with your work email.
Combotope Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Combotope Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BioInnovation Institute | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 10, 2026
$580K raised from BioInnovation Institute
For institutional investors. Book with your work email.
Combotope Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Combotope Therapeutics's valuation, stock price, and market status.
Is Combotope Therapeutics a public or private company?
Combotope Therapeutics is a private company.
What is the current stock price of Combotope Therapeutics?
Combotope Therapeutics is a private company, so its shares have no public market price. Caplight tracks Combotope Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Combotope Therapeutics worth (valuation)?
Valuation information for Combotope Therapeutics is not publicly available.
Can I buy Combotope Therapeutics stock?
Combotope Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Combotope Therapeutics's last funding round?
Combotope Therapeutics's most recent funding round was Accelerator on March 10, 2026.
Who are the main investors in Combotope Therapeutics?
Key investors in Combotope Therapeutics include BioInnovation Institute.
Will Combotope Therapeutics IPO soon?
No public IPO plans have been announced for Combotope Therapeutics.
How can I track Combotope Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Combotope Therapeutics's shares on secondary markets.